With the aim of improving and providing museum visitors with a personalised experience, on Thursday, 19 January, Barcelona's Hash Marihuana & Hemp Museum, presented its new audio-guide service, which is already available in six different languages, allowing visitors to browse the collection at their own pace and as they choose.
In December 2016, the DEA dealt a fresh blow to cannabis. All cannabis extracts, including CBD, are classified under Schedule I of Controlled Substances as drugs with no medical use. The DEA again ignores scientific progress and legalisation campaigns, as well as patients who are already benefiting from the therapeutic applications of cannabis.
We call locale-specific varieties of cannabis “landraces”, and they are the backbone of modern commercially-bred cannabis seeds. But these landraces are under threat from habitat loss, government eradication programs, and invasion of foreign varieties. Let’s take a look at how this occurs, and what we can do to preserve our remaining landrace genepool.
In Europe, there is currently a political cross-party consensus: cannabis is okay, as long as it is being used for medicinal purposes. Anything else should continue to be banned and in that context, many people are busily trying to keep the two discussions well apart from each other. None of the large right-wing parties, addiction researchers, doctors and even patient associations adopt a prohibitionist stance when talking about the re-legalisation of cannabis. "This question," they always say, "Has nothing to do with the other question. The medicinal use we are talking about is to reduce the symptoms of disease; recreational use is just about getting high."
CannaZapp gives you a guided tour of the most extreme reactions to cannabis. Watch this 14th episode to find out what this looks like.
Since the use of cannabis as medication for and by patients was legalised in Germany by the taking of legal action, people in possession of a “Certificate of Exemption for Self-Treatment with Medicinal Hemp Buds whilst under Medical Supervision” shouldn't actually need to worry any more about having trouble with the law due to this otherwise prohibited plant. However...
A few months ago, the Sensi Seeds team was lucky to meet eminent French artist Shurik’n. This week, Shurik’n is releasing the video for “Où te mèneront tes pas”. And we at Sensi Seeds, could not be more excited!
The international movement to legalise and regulate cannabis has achieved such staggering success in recent years that the cause has now become mainstream, and an increasingly significant political issue in dozens of countries worldwide. After the successes of last year, what does 2017 hold for the cannabis industry?
Two Amsterdam-based chefs are putting a new twist on some very old highs, creating haute cuisine dishes incorporating mind-altering herbs from around the world. After a successful local start, they’re hoping to make their High Cuisine concept a new culinary wave worldwide with a cookery book and TV series.
For certain conditions, cannabis and cannabis-based medicines may be safer and more effective than current standard treatments. Medicinal cannabis patients in the US and elsewhere are beginning to replace or supplement conventional pharmaceuticals with cannabis, with very promising initial results.
In breaking news, the Dutch company Bedrocan has been recognised as compliant with the European Medicines Agency’s good manufacturing practice (GMP) standards. This is the highest level of compliance ever achieved by a medicinal cannabis company.
The name “Hash Plant” really couldn’t be any more self-explanatory, now could it? Yet, this strain is so much more complex than its name. More here.
Today is Inauguration Day. What will be the stance of President Donald Trump on cannabis? Will he adopt a cannabis-friendly approach or enforce a zero-tolerance policy? Micha, a journalist and cannabis expert, provides us with some insights.
The Global Commission on Drug Policy, comprised of 23 renowned key political and intellectual figures, has presented its 2016 report, advocating the worldwide decriminalisation of all drugs and recommending the abolition of criminal and civil penalties, which continue to be in force for the use and possession of drugs in much of the world.
Following his election victory, Canada’s Prime Minister Trudeau announced that he would regulate the buying and selling of cannabis. In mid-December 2016, the task force he brought in especially for this purpose made a proposal, which dealt with no less than 80 detailed questions about the upcoming legalisation. Read more about the legalisation of cannabis in Canada here.
Following the Supreme Court's judgements against cannabis clubs in 2015, ordinary courts have started interpreting them. Spain's major clubs, above all in Barcelona, appear to have their days numbered. However, increasingly more judges understand that small clubs fit in with the Law. A new era is dawning.
On the 30th of November 2016, an International Conference on Medical Cannabis was held for the first time in the European Parliament. Politicians gathered with a range of patients, activists, campaigners, entrepreneurs and scientists from the European cannabis community to discuss the future of the industry.
You may be aware of some of the applications of cannabis and cannabinoids in treating a long list of diseases. Today we focus on its therapeutic potential to prevent and treat bone injuries or diseases, an area of medical application where research conducted over the last few years has yielded very promising results.
In late September 2016, the Federal Institute for Drugs and Medical Devices (BfArM) issued the first ever licence to a German cannabis patient to grow their own medicinal cannabis. Michael F., who is living with multiple sclerosis, took his demand for the right to grow at home as part of his government-recognised therapy to the highest court in the land for this matter. He won his case on 6 April of this year.